Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
In a report released today, John McDonald CFA from Truist Financial assigned a Hold rating to JPMorgan Chase & Co. (JPM – Research Report).
JPMorgan’s net income soared 50% to more than $14 billion in the fourth quarter as the bank’s profit and revenue easily beat ...
In a report released today, Glenn Schorr from Evercore ISI maintained a Buy rating on JPMorgan Chase & Co. (JPM – Research Report), with a ...
UBS increased their price target for JPMorgan shares, listed on the New York Stock Exchange (NYSE:JPM), to $287 from the ...
It's not just JPMorgan Chase. Across the industry, banks are rethinking their remote-work policies — but experts say it won't ...
In addition to reporting 2024 revenue at the lower end of its previous guided range, Moderna issued a disappointing forward ...
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains ...
JPMorgan Chase's annual profit rose to a record as its dealmakers and traders reaped a windfall from rebounding markets in ...
JPMorgan Chase's reported on Wednesday a more than 50% jump in net income for the fourth quarter, primarily helped by growth in revenue. The US financial services firm's earnings, as well as revenue, ...